Title: Chronic effects of oxytocin: Are we ready for its therapeutic use?

**Abstract**

Due to its acute pro-social and anxiolytic properties, and the attenuation of stress responses the neuropeptide OXT has received substantial interest. We have recently shown that OXT promotes social preference behaviour and prevents social phobia induced by social defeat stress in rats and mice^1^. Further, in a mouse paradigm for social fear conditioning^2^, OXT specifically reversed social fear -- an effect which was localized within the dorsolateral septum, where social fear was associated with reduced OXT receptor binding^3^.

In contrast to its acute effects, chronic central OXT infusion over 14 days using osmotic minipumps dose-dependently increased anxiety of male mice and reduced OXT receptor binding in the basolateral amygdala, nucleus raphe and dorsolateral septum. At lower dose, continuous chronic infusion of OXT was able to prevent a variety of chronic stress-induced mal-adaptations. We are currently studying the consequences of chronic OXT on OXT receptor-coupled intracellular signaling pathways in males and females.

Although the acute effects point towards the therapeutic use of OXT for anxiety-related disorders including social phobia more detailed behavioral and molecular studies are needed to reveal chronic effects.
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